Therefore, we can conclude that NR4A2 is a potential therapeutic target for neurological and/or psychiatric diseases, due to its key role in the survival of dopaminergic neurons, as well as in the regulation of neuroinflammation and neuronal plasticity, among other functions. This evidence concerns the gene NR4A2 and psychiatric disorder.